Atezolizumab-Induced Autoimmune Diabetes in a Patient With Metastatic Lung Cancer

Context: Immune checkpoint inhibitors (ICIs), now FDA-approved, are increasingly used as an effective treatment of various cancers. Autoimmune diabetes is a rare but life-threatening endocrine adverse event, which has been reported in patients treated with anti-programmed-cell death-1 (anti-PD-1) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Sothornwit, Jin, Phunmanee, Anakapong, Pongchaiyakul, Chatlert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581023/
https://www.ncbi.nlm.nih.gov/pubmed/31244772
http://dx.doi.org/10.3389/fendo.2019.00352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581023/
https://www.ncbi.nlm.nih.gov/pubmed/31244772
http://dx.doi.org/10.3389/fendo.2019.00352

Ejemplares similares